Literature DB >> 12630667

Interaction of Borrelia burgdorferi sensu lato with Epstein-Barr virus in lymphoblastoid cells.

D Hulínská1, K Roubalová, J Schramlová.   

Abstract

Since the possibility of interruption of latent EBV infection has been suggested by the induction of the lytic virus cycle with chemical substances, other viruses, and by immunosuppression, we hypothesized that the same effect might happen in B. burgdorferi sensu lato infection as happens in Lyme disease patients with positive serology for both agents. We have observed EBV replication in lymphoblastoid cells after superinfection with B. garinii and B. afzelii strains after 1 and 4 h of their interaction. We found that viral and borrelial antigens persisted in the lymphoblasts for 3 and 4 days. Morphological and functional transformation of both agents facilitate their transfer to daughter cells. Association with lymphoblasts and internalization of B. garinii by tube phagocytosis increased replication of viruses more successfully than B. afzelii and chemical inductors. Demonstration of such findings must be interpreted cautiously, but may prove a mixed borrelial and viral cause of severe neurological disease.

Entities:  

Mesh:

Year:  2003        PMID: 12630667

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  3 in total

1.  Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity.

Authors:  M Kleines; J Schiefer; A Stienen; M Blaum; K Ritter; M Häusler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-15       Impact factor: 3.267

2.  Short-term stability of Borrelia garinii in cerebrospinal fluid.

Authors:  Dagmar Berenová; Daniel Krsek; Lenka Šípková; Alena Lukavská; Marek Malý; Zuzana Kurzová; Jan Hořejší; Petr Kodym
Journal:  Folia Microbiol (Praha)       Date:  2015-06-24       Impact factor: 2.099

3.  Infectious Mononucleosis and Lyme Disease as Confounding Diagnoses: A Report of 2 Cases.

Authors:  Trever M Koester; Jennifer K Meece; Thomas R Fritsche; Holly M Frost
Journal:  Clin Med Res       Date:  2018-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.